Home/ Supplements/ Omega 3/ Pur Omega

Pur Omega

product on market Softgel Capsule Oceanblue Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids are supported by strong evidence for promoting cardiovascular health and reducing systemic inflammation. The remaining listed components are basic nutritional values rather than active ingredients. Research indicates these fatty acids are generally safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Pur Omega
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (1% DV)
Cholesterol
5 mg (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

highly refined and concentrated Omega-3 Marine Oil Capsule Shell natural mixed Tocopherols
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take two (2) softgel capsules daily with meal.

Warnings & Precautions

Allergen Warning: Contains fish and soy derivatives.

Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Free of: Gluten, lactose, milk, eggs, peanuts, tree nuts, crustacean shellfish, artificial colors or flavors.

900 mg omega-3

Ultra-pure High potency 90% pure

470 EPA 330 DHA

Additional Information

Store in a cool dry place.

Metadata

Product Details

DSLD Entry Date2021-02-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID243738
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.